ZLDPF - Zealand Pharma releases top-line phase 2 results on weight loss asset dapiglutide
2024-05-24 10:40:44 ET
More on Zealand Pharma
- Zealand Pharma A/S (ZLDPF) Q1 2024 Earnings Call Transcript
- Zealand Pharma: Survodutide Has Potential Beyond Obesity Treatment
- Zealand Pharma A/S (ZEAL) Q4 2023 Earnings Call Transcript
- Historical earnings data for Zealand Pharma
- Financial information for Zealand Pharma